On ECHEMI
Home > Drugs > Etoposide Phosphate for Injection

Etoposide Phosphate for Injection

Indication

This product is suitable for the treatment of the following tumors: 1. Refractory testicular tumors - patients with refractory testicular tumors after appropriate surgery, chemotherapy and radiotherapy can be treated with this product in combination with other approved chemotherapy drugs; 2. Small cell lung cancer - injection of etoposide phosphate combined with other approved chemotherapy drugs as the first-line drug for patients with small cell lung cancer.

Precautions

1. Patients with a history of allergy to etoposide phosphate, etoposide and any of the components of this product are contraindicated; 2. Children, pregnant women and lactating women should use it with caution.

Special Population Medication

Precautions for children: Use with caution in children. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women.

Packaging Specification

100mg (as etoposide)

Manufacturer

Hainan Tongyong Kangli Pharmaceutical Co., Ltd.

  • Founded in:

    2000-05-16
  • Address:

    Room 221-226, Building 1, No. 269, Nanhai Avenue, National High-tech Industrial Development Zone, Haikou City, Hainan Province
  • Tax NO.:

    914600007212236930
  • Registered Funds:

    50 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.